Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 5, Issue 8, 2023

Experiences in Treating Cases of Gastrointestinal Heat Accumulation-Type Constipation-Type Irritable Bowel Syndrome with the Use of Jiawei Zuojin Pill

Download as PDF

DOI: 10.23977/medcm.2023.050811 | Downloads: 37 | Views: 571

Author(s)

Zhang Huayi 1, Hui Jianping 2, Li Xinyi 1, Jia Lingna 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Corresponding Author

Hui Jianping

ABSTRACT

Constipated-predominant irritable bowel syndrome (IBS-C) is one of the functional gastrointestinal disorders with an increasing global incidence year by year. The pathogenesis of IBS-C is currently unclear. Modern medical researchers still use the regulation of gastrointestinal dynamics, relieve gastrointestinal spasm, improve the microecological environment of the gastrointestinal tract and psychotherapy and other symptomatic treatment means, but often the efficacy is very small. And because IBS-C has a tendency to recur. It puts a very high level of financial and psychological pressure on the patient. In Chinese medical understanding, according to the characteristics of the pathogenesis of IBS-C and its clinical manifestations of abdominal pain and bowel difficulties, it is classified under the related names of "constipation, abdominal pain, intestinal knot". And IBS-C can be classified as gastrointestinal accumulation of heat type IBS-C by Chinese medicine diagnosis, combine the etiology and pathogenesis of gastrointestinal heat accumulation type IBS-C and the patient's morbid characteristics, examine the evidence and seeking the cause, and combining the four diagnoses. Chinese medicine practitioners chose the classic formula Jiawei Zuojin Pill, with its treatment of clearing the fire of the liver and stomach and regulating the qi of the liver and stomach, to adjust the functions of the internal organs, and make the stools smooth. Therefore, the efficacy of Zuojin Pills is widely praised by patients. The therapeutic means of TCM was then explored as a new development in the treatment of IBS-C. 

KEYWORDS

Constipated-predominant irritable bowel syndrome; Stomach and intestinal heat accumulation type; Jiawei Zuojin Pill; Chinese medicine therapy

CITE THIS PAPER

Zhang Huayi, Hui Jianping, Li Xinyi, Jia Lingna, Experiences in Treating Cases of Gastrointestinal Heat Accumulation-Type Constipation-Type Irritable Bowel Syndrome with the Use of Jiawei Zuojin Pill. MEDS Chinese Medicine (2023) Vol. 5: 80-87. DOI: http://dx.doi.org/10.23977/medcm.2023.050811.

REFERENCES

[1] Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV[J]. Gastroenterology, 2016, 150(6): 1262-1279. 
[2] Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress [J]. Aliment Pharmacol Ther, 1997, 11(2): 395-402. 
[3] Zhao Erying, Zhou Jiawei, Chu Haiyun, et al. Epidemiology and pathogenic factors of irritable bowel syndrome: a review on research progress [J]. Chinese Journal of Public Health, 2021, 37(04): 764-768. 
[4] Yang Xiao, Wu Fucang, Kan Xiangling. Experience of treating diarrhea type irritable bowel syndrome based on "visceral hypersensitivity theory" [J]. Journal of Tianjin University of Traditional Chinese Medicine, 2022, 41(06): 706-709. 
[5] Chen Xiaoteng. Ma Weiming's experience in identifying and treating irritable syndrome [J]. Zhejiang Journal of Traditional Chinese Medicine, 2009, 44(09): 637. 
[6] Cao Zihan, Cao Zhiqun. Advances in TCM Treatment of Constipation-Type Irritable Bowel Syndrome [J]. Traditional Chinese Medicine Journal, 2023, 22(03): 69-72. 
[7] Zhang Xu, Hu Yan, Xiao Ting, et al. Han Shutang’s Experience in Treating Constipation Irritable Bowel Syndrome[J]. Asia-Pacific Traditional Medicine, 2021, 17(7): 126-128. 
[8] Wei Cuiping. Effectiveness of Lizhong Tang combined with Hovenia Tang in the adjuvant treatment of constipation-type irritable bowel syndrome [J]. The Journal of Medical Theory and Practice, 2021, 34(14): 2431-2433. 
[9] Zhang Jiahe, Li Hui. Study on the Prescription Rule of Traditional Chinese Medicine in theTreatment of Constipation Predominant Irritable Bowel Syndrome [J]. Chinese Journal of Ethnomedicine and Ethnopharmacy, 2021, 30(12): 9-13. 
[10] Huang Chiyao, Yi Wen. Research progress of Chinese medicine treatment of constipated irritable bowel syndrome [J]. Guangming Journal of Chinese Medicine, 2021, 36(9): 1539-1541. 
[11] Lv Yaping, Ma Lei, Wang Delong, et al. An analysis of the treatment of constipation-type irritable bowel syndrome by the method of opening depression and moistening the spleen [J]. Zhejiang Journal of Traditional Chinese Medicine, 2021, 56(4): 302. 
[12] Gu Juan, Li Zeng. Treatment of constipation-type irritable bowel syndrome based on "facilitating hepatic stagnation" theory [J]. Clinical Journal of Chinese Medicine, 2023, 15(03): 69-71. 
[13] Zhang Liju, Zhang Baixue, Liu Shaoneng. Experience and experience in treating functional constipation from liver theory [J]. Hebei Journal of Traditional Chinese Medicine, 2023, 45(04): 651-654. 
[14] Kong Weijun, Zhao Yanling, Shan Limei, et al. Progress of Zuojinwan [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2008(05): 73-77. 
[15] Chen Huipeng, Wang Yin, Chen Xiangling, et al. Simultaneous determination of 13 bioactive components in Jiawei Zuojin Pill by HPLC-MS/MS[J]. Chinese Traditional and Herbal Drugs, 2020, 51(14): 3693-3699. 
[16] Luo Zhongqiu. Treatment of intractable constipation with Jiawei Zuojin Wan [J]. Jiangxi Journal of Traditional Chinese Medicine, 2005(02): 59.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4232
Visits: 167537

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.